SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-145158
Filing Date
2021-04-30
Accepted
2021-04-30 16:18:57
Documents
13
Period of Report
2021-04-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d127648d8k.htm   iXBRL 8-K 28726
2 EX-5.1 d127648dex51.htm EX-5.1 7484
  Complete submission text file 0001193125-21-145158.txt   166992

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tcrr-20210430.xsd EX-101.SCH 3093
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrr-20210430_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrr-20210430_pre.xml EX-101.PRE 11875
6 EXTRACTED XBRL INSTANCE DOCUMENT d127648d8k_htm.xml XML 3450
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38811 | Film No.: 21878335
SIC: 2836 Biological Products, (No Diagnostic Substances)